These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Tuning the cytotoxicity of ruthenium(ii) para-cymene complexes by mono-substitution at a triphenylphosphine/phenoxydiphenylphosphine ligand. Biancalana L; Zacchini S; Ferri N; Lupo MG; Pampaloni G; Marchetti F Dalton Trans; 2017 Dec; 46(47):16589-16604. PubMed ID: 29164209 [TBL] [Abstract][Full Text] [Related]
8. Comparative solution equilibrium studies of antitumor ruthenium(η Dömötör O; Pape VFS; May NV; Szakács G; Enyedy ÉA Dalton Trans; 2017 Mar; 46(13):4382-4396. PubMed ID: 28287667 [TBL] [Abstract][Full Text] [Related]
9. Luminescent anticancer Ru(II)-arenebipyridine and phenanthroline complexes: Synthesis, characterization, DFT studies, biological interactions and cellular imaging application. P K A; Paira P J Inorg Biochem; 2020 Jul; 208():111099. PubMed ID: 32460056 [TBL] [Abstract][Full Text] [Related]
10. Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties. Ludwig G; Kaluđerović GN; Bette M; Block M; Paschke R; Steinborn D J Inorg Biochem; 2012 Aug; 113():77-82. PubMed ID: 22698819 [TBL] [Abstract][Full Text] [Related]